124 related articles for article (PubMed ID: 38814321)
21. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
Macedo FI; Mittal VK
Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
[TBL] [Abstract][Full Text] [Related]
22. Controversy: For or against thyroid lobectomy in>1cm differentiated thyroid cancer?
Menegaux F; Lifante JC
Ann Endocrinol (Paris); 2021 Apr; 82(2):78-82. PubMed ID: 33757822
[TBL] [Abstract][Full Text] [Related]
23. Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.
Raffaelli M; Tempera SE; Sessa L; Lombardi CP; De Crea C; Bellantone R
Gland Surg; 2020 Jan; 9(Suppl 1):S18-S27. PubMed ID: 32055495
[TBL] [Abstract][Full Text] [Related]
24. Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer.
Di Filippo L; Giugliano G; Tagliabue M; Gandini S; Sileo F; Allora A; Grosso E; Proh M; Basso V; Scaglione D; Manzoni MF; Ansarin M
Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):254-261. PubMed ID: 33100336
[TBL] [Abstract][Full Text] [Related]
25. Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Song E; Ahn J; Song DE; Kim WW; Jeon MJ; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
Clin Endocrinol (Oxf); 2020 Apr; 92(4):358-365. PubMed ID: 31630423
[TBL] [Abstract][Full Text] [Related]
26. Effect of prophylactic central neck dissection following total thyroidectomy on surgical site wound infection, hematoma, and haemorrhage in subjects with clinically node-negative papillary thyroid carcinoma: A meta-analysis.
Jin L; Liu L; Wang J; Zhang L
Int Wound J; 2023 Feb; 20(2):251-260. PubMed ID: 35702946
[TBL] [Abstract][Full Text] [Related]
27. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis.
Esnaola NF; Cantor SB; Sherman SI; Lee JE; Evans DB
Surgery; 2001 Dec; 130(6):921-30. PubMed ID: 11742318
[TBL] [Abstract][Full Text] [Related]
28. Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
MacKinney EC; Kuchta KM; Winchester DJ; Khokar AM; Holoubek SA; Moo-Young TA; Prinz RA
Surgery; 2022 Jan; 171(1):197-202. PubMed ID: 34666913
[TBL] [Abstract][Full Text] [Related]
29. Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis.
Zhang C; Li Y; Li J; Chen X
Medicine (Baltimore); 2020 Feb; 99(6):e19073. PubMed ID: 32028431
[TBL] [Abstract][Full Text] [Related]
30. Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.
Bakkar S; Al-Omar K; Donatini G; Aljarrah Q; Papavramidis TS; Materazzi G; Miccoli P
Endocrine; 2021 Dec; 74(3):611-615. PubMed ID: 34110601
[TBL] [Abstract][Full Text] [Related]
31. Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
Back K; Lee J; Choe JH; Kim JH; Oh YL; Kim JS
Am J Surg; 2022 Apr; 223(4):635-640. PubMed ID: 34446213
[TBL] [Abstract][Full Text] [Related]
32. Complication Rates of Total Thyroidectomy vs Hemithyroidectomy for Treatment of Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.
Hsiao V; Light TJ; Adil AA; Tao M; Chiu AS; Hitchcock M; Arroyo N; Fernandes-Taylor S; Francis DO
JAMA Otolaryngol Head Neck Surg; 2022 Jun; 148(6):531-539. PubMed ID: 35511129
[TBL] [Abstract][Full Text] [Related]
33. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
34. Comparison of total endoscopic thyroidectomy with conventional open thyroidectomy for treatment of papillary thyroid cancer: a systematic review and meta-analysis.
Jiang WJ; Yan PJ; Zhao CL; Si MB; Tian W; Zhang YJ; Tian HW; Feng SW; Han CW; Yang J; Yang KH; Guo TK
Surg Endosc; 2020 May; 34(5):1891-1903. PubMed ID: 32144555
[TBL] [Abstract][Full Text] [Related]
35. Contralateral Low-to-Intermediate Suspicion Nodule Is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma.
Pak SJ; Kwon D; Kim BC; Cho JW; Kim WW; Lee YM; Sung TY; Baek JH; Kim WG; Kim WB; Chung KW
Thyroid; 2023 Nov; 33(11):1339-1348. PubMed ID: 37624735
[No Abstract] [Full Text] [Related]
36. Favorable Early Outcomes With Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: The Mayo Clinic Experience.
Merten MM; Foster T; Lyden M; Henry M; Regina Castro M
Am Surg; 2021 Sep; 87(9):1374-1378. PubMed ID: 34468234
[TBL] [Abstract][Full Text] [Related]
37. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
38. Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis.
Liang W; Shi J; Zhang H; Lv G; Wang T; Wang Y; Lv B; Li L; Zeng Q; Sheng L
Surgery; 2022 Nov; 172(5):1385-1391. PubMed ID: 35995619
[TBL] [Abstract][Full Text] [Related]
39. Low-risk differentiated thyroid cancer: the need for selective treatment.
Shaha AR; Shah JP; Loree TR
Ann Surg Oncol; 1997 Jun; 4(4):328-33. PubMed ID: 9181233
[TBL] [Abstract][Full Text] [Related]
40. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
